| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4bdedfd6468f2e405e46e46b120f3be1 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2020-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fd222852919f42e0f4f9377ffffa11f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8e6dccdb743069c4f4b838d1990c7f3 |
| publicationDate |
2021-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-112679487-A |
| titleOfInvention |
4-(5-(Cyclohexyloxy)pyridin-2-yl)morpholine-2,6-dione and its preparation method and application |
| abstract |
The invention belongs to the field of medicine and relates to 4-(5-(cyclohexyloxy)pyridine-2-yl)morpholine-2,6-dione and a preparation method and application thereof. Described 4-(5-(cyclohexyloxy) pyridine-2-yl) morpholine-2,6-dione structural formula is shown in formula I: Pharmacological studies show that the compounds prepared by the present invention, as corticotropin-releasing factor (CRF) receptor antagonists, can be used to treat central nervous system disorders and stress-related disorders caused by the increase of endogenous levels of CRF. |
| priorityDate |
2020-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |